Director Gold Alexander M sold all 34,675 shares (34.7K) for $1.6M blended at $45.45, exiting completely from unprofitable MLYS.
Director Gold Alexander M executed 5 separate sales totaling 34,675 shares for $1,576,094.67 on November 11–13, 2025, liquidating his entire stake at a blended average price of $45.45. The stock currently trades at $44.29, down 6.4% from its 52-week high of $47.33, and Mineralys Therapeutics reported a net loss of $36,932,000.00 over its most recent full fiscal year. This complete exit by a board member of an unprofitable biotech company during a period of significant recent volatility—the stock has risen 205.0% over the past 90 days—represents a material reduction in insider ownership exposure and aligns with the company's negative profitability profile.